These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2558265)

  • 1. Kappa opioid receptors of human placental villi modulate acetylcholine release.
    Ahmed MS; Schoof T; Zhou DH; Quarles C
    Life Sci; 1989; 45(25):2383-93. PubMed ID: 2558265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid receptors of human placental villi modulate acetylcholine release.
    Ahmed MS; Horst MA
    Life Sci; 1986 Aug; 39(6):535-40. PubMed ID: 3016443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
    Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
    Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phencyclidine-induced inhibition of striatal acetylcholine release: comparisons with mu, kappa, and sigma opiate agonists.
    Leventer SM; Johnson KM
    Life Sci; 1984 Feb; 34(8):793-801. PubMed ID: 6366418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of opioids on acetylcholine release evoked by K+ or glutamic acid from rat neostriatal slices.
    Arenas E; Alberch J; Sanchez Arroyos R; Marsal J
    Brain Res; 1990 Jul; 523(1):51-6. PubMed ID: 1976420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiates inhibit acetylcholine release from Torpedo nerve terminals by blocking Ca2+ influx.
    Michaelson DM; McDowall G; Sarne Y
    J Neurochem; 1984 Sep; 43(3):614-8. PubMed ID: 6431053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
    Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
    Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
    Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioids regulate the release of human chorionic gonadotropin hormone from trophoblast tissue.
    Cemerikic B; Cheng J; Agbas A; Ahmed MS
    Life Sci; 1991; 49(11):813-24. PubMed ID: 1652048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid and non-opioid actions of loperamide on cholinergic nerve function in human isolated colon.
    Burleigh DE
    Eur J Pharmacol; 1988 Jul; 152(1-2):39-46. PubMed ID: 2850201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of opioids on acetylcholine output of perfused human placental cotyleda.
    Gude NM; Krishna BR; King RG; Brennecke SP; Boura AL
    Placenta; 1989; 10(5):445-52. PubMed ID: 2674931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu and kappa opioids inhibit transmitter release by different mechanisms.
    Cherubini E; North RA
    Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1860-3. PubMed ID: 2984670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine-naloxone interaction in the central cholinergic system: the influence of subcortical lesioning and electrical stimulation.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1976 Sep; 58(1):101-7. PubMed ID: 974367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of L-type calcium channels associated with kappa opioid receptors in human placenta.
    Cemerikic B; Zamah R; Ahmed MS
    J Mol Neurosci; 1998 Jun; 10(3):261-72. PubMed ID: 9770647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional role of opioid receptors in acetylcholine release in the rat adrenal medulla.
    Hirokami M; Togashi H; Matsumoto M; Yoshioka M; Saito H
    Eur J Pharmacol; 1994 Feb; 253(1-2):9-15. PubMed ID: 8013552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.